Polarean Drug Patent Portfolio
Polarean owns 1 orange book drug protected by 2 US patents Given below is the list of Polarean's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11052161 | Hyperpolarized noble gas production systems with nanocluster suppression, detection and/or filtering and related methods and devices | 29 Dec, 2035 | Active |
| US10583205 | Hyperpolarized noble gas production systems with nanocluster suppression, detection and/or filtering and related methods and devices | 20 Feb, 2035 | Active |
Latest Legal Activities on Polarean's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Polarean.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Yr, Small Entity | 23 Aug, 2023 | US10583205 |
| Post Issue Communication - Certificate of Correction | 09 Nov, 2021 | US11052161 |
|
Email Notification
Critical
| 04 Nov, 2021 | US11052161 |
| Mail Certificate of Correction Memo | 03 Nov, 2021 | US11052161 |
| Certificate of Correction Memo | 01 Nov, 2021 | US11052161 |
|
Recordation of Patent Grant Mailed
Critical
| 06 Jul, 2021 | US11052161 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 06 Jul, 2021 | US11052161 |
|
Email Notification
Critical
| 17 Jun, 2021 | US11052161 |
|
Issue Notification Mailed
Critical
| 16 Jun, 2021 | US11052161 |
| Dispatch to FDC | 01 Jun, 2021 | US11052161 |
|
Application Is Considered Ready for Issue
Critical
| 28 May, 2021 | US11052161 |
|
Issue Fee Payment Verified
Critical
| 27 May, 2021 | US11052161 |
|
Issue Fee Payment Received
Critical
| 27 May, 2021 | US11052161 |
| Mail Post Card | 01 Apr, 2021 | US11052161 |
|
Email Notification
Critical
| 24 Mar, 2021 | US11052161 |
Polarean's Family Patents
Polarean drugs have patent protection in a total of 6 countries. It has a significant patent presence in the US with 58.3% of its patents being US patents. Click
below to unlock the full patent family tree.
Polarean Drug List
Given below is the complete list of Polarean's drugs and the patents protecting them.
1. Xenoview
Xenoview is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11052161 | Hyperpolarized noble gas production systems with nanocluster suppression, detection and/or filtering and related methods and devices |
29 Dec, 2035
(11 years from now)
| Active |
| US10583205 | Hyperpolarized noble gas production systems with nanocluster suppression, detection and/or filtering and related methods and devices |
20 Feb, 2035
(10 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Xenoview's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List